SCHEMBL6904792

SCHEMBL6904792

CCOc1cc(C(C#N)=Cc2ccncc2)ccc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 11/20 0.55
▸ PDE4B Q07343 11/20 0.55
▸ PDE4C Q08493 11/20 0.55
▸ PDE4D Q08499 11/20 0.55
▸ RECQL P46063 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ EGFR P00533 1/20 0.52
▸ PDGFRB P09619 1/20 0.52
▸ PDGFRA P16234 1/20 0.52
▸ TUBB4A P04350 4/20 0.48
▸ TUBB P07437 4/20 0.48
▸ TUBA3C P0DPH7 4/20 0.48
▸ TUBA1B P68363 4/20 0.48
▸ TUBA4A P68366 4/20 0.48
▸ TUBB4B P68371 4/20 0.48
▸ TUBB3 Q13509 4/20 0.48
▸ TUBB2A Q13885 4/20 0.48
▸ TUBB8 Q3ZCM7 4/20 0.48
▸ TUBA3E Q6PEY2 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6904789 1.00 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DRECQL
SCHEMBL1959906 0.90 SMN1; SMN2 (0.62) PDE4BRECQLSMN1; SMN2HIF1AEGFR
SCHEMBL1959904 0.90 SMN1; SMN2 (0.62) PDE4BRECQLSMN1; SMN2HIF1AEGFR
Hydrochloric Acid SCHEMBL1959669 0.89 SMN1; SMN2 (0.60) PDE4BRECQLSMN1; SMN2HIF1AEGFR
Hydrochloric Acid SCHEMBL1959671 0.89 SMN1; SMN2 (0.60) PDE4BRECQLSMN1; SMN2HIF1AEGFR
SCHEMBL1957258 0.83 RECQL (0.55) PDE4BRECQLSMN1; SMN2HIF1AEGFR
SCHEMBL1957259 0.83 RECQL (0.55) PDE4BRECQLSMN1; SMN2HIF1AEGFR
SCHEMBL5190968 0.80 PDE4A (0.50) PDE4APDE4BPDE4CPDE4DTUBB4A
SCHEMBL4990088 0.80 MEN1 (0.59) PDE4APDE4BPDE4CPDE4DRECQL
SCHEMBL4990101 0.80 MEN1 (0.59) PDE4APDE4BPDE4CPDE4DRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040019106-A1 Novel immunotherapeutic agents MULLER GEORGE W (US) 2004-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019106-A1 Novel immunotherapeutic agents NFKBIA, RELA, IKBKG PDE4A 22/4885PDE4B 33/4885PDE4C 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback